Sunday, March 26, 2023
manilastandard.net
ADVERTISEMENT
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Others
    • Pets
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Technology
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • MS ON THE ROAD
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Gallery
      • Photos
      • Videos
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
  • Advertise with Us
No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Others
    • Pets
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Technology
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • MS ON THE ROAD
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Gallery
      • Photos
      • Videos
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
  • Advertise with Us
No Result
View All Result
manilastandard.net
No Result
View All Result
Home News Coronavirus 2019

WHO ‘strongly recommends’ Pfizer’s Covid pill

AFPbyAFP
April 22, 2022, 7:21 am
in Coronavirus 2019, World News
Reading Time: 3 mins read
A A
Share on FacebookShare on TwitterShare on Email

The World Health Organization said Friday it “strongly recommended” Pfizer’s Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.

However the UN agency warned it was “extremely concerned” that the inequality in access seen with Covid vaccines would again leave low- and middle-income countries “pushed to the end of the queue”.

US pharma giant Pfizer’s combination of nirmatrelvir and ritonavir was the “superior choice” of treatment for unvaccinated, elderly or immunocompromised people with Covid, the WHO’s experts said in the BMJ medical journal.

For the same patients, the WHO also made a “conditional (weak) recommendation” of the antiviral drug remdesivir made by US biotech firm Gilead — which it had previously recommended against.

The WHO recommended Paxlovid over remdesivir, as well as over Merck’s molnupiravir pill and monoclonal antibodies.

ADVERTISEMENT

Pfizer’s oral treatment prevents hospitalisation more than the “available alternatives, has fewer concerns with respects to harms than molnupiravir, and is easier to administer than intravenous remdesivir and antibodies,” the WHO’s experts said.

The new recommendation was based on the findings of two trials involving almost 3,100 patients which showed that Paxlovid reduced the risk of hospital admission by 85 percent.

The trials also “suggested no important difference in mortality” and “little or no risk of adverse effects leading to drug discontinuation”. 

The recommendation applies to people over the age of 18, but not to pregnant or breastfeeding women.

It also does not apply to patients with a low risk of complications from the disease, because the benefit would be minimal.

The WHO’s experts also declined to give an opinion for patients with severe forms of the disease, due to a lack of data.

– Limitations and inequities –

The WHO stressed the limitations of such antiviral treatments. 

“The medicine can only be administered while the disease is at its early stages,” they said.

This means the patients must quickly test positive and be prescribed the pill by a doctor — all of which can pose obstacles for low- and middle-income countries, the WHO said.

Yet Covid pills have been seen as a potentially huge step in ending the pandemic as they can be taken at home, rather than in hospital.

Patients must start taking their Paxlovid pills within five days of the onset of symptoms — the course then lasts five days.

Remdesivir can be taken within seven days of symptoms setting in, but it is administered intravenously over three days.

– Questions about cost –

The WHO called on Pfizer to “make its pricing and deals more transparent” for Paxlovid.

Lisa Hedman, the WHO’s senior advisor on access to medicines, said that radio station NPR reported a full course of Paxlovid costs $530 in the United States. Another source unconfirmed by WHO gave the price of $250 in an upper-middle income country.

Remdesivir meanwhile costs $520, Hedman said, but generic versions made by companies in India sell for $53-$64. 

There is also a question mark over whether the virus could build resistance to these treatments.

But earlier this month Pfizer CEO Albert Bourla predicted a bright future for treatments like Paxlovid as people grow tired of getting further booster vaccinations.

Coming under fire for prioritising wealthy countries with its vaccine, Pfizer has agreed to allow some generic drugmakers around the world to make cheaper versions of Paxlovid under a UN-backed scheme. 

But on Friday the WHO “strongly recommended” that Pfizer let more generic manufacturers produce the drug and “make it available faster at affordable prices”.

Tags: corona virusPfizerWHO
ADVERTISEMENT
AFP

AFP

Related Posts

Tornado kills at least 25 in Mississippi

byAFP
March 26, 2023, 9:10 pm
0
8
Pause Israel reforms, defense minister urges

ROLLING FORK – At least 25 people were killed by devastating tornadoes that ripped across the southern US state of...

Read more

Fresh protests in France shift to water dispute

byAFP
March 26, 2023, 9:00 pm
0
8
French protests over pension reform go on

SAINTE-SOLINE – French police again clashed with protesters Saturday as campaigners in the southwest sought to stop the construction of...

Read more

Pause Israel reforms, defense minister urges

byAFP
March 26, 2023, 8:50 pm
0
8
Pause Israel reforms, defense minister urges

TEL AVIV – Tens of thousands of Israelis rallied in Tel Aviv Saturday against a controversial judicial overhaul, as Defence...

Read more

Scholz looks to quell coalition divisions

byAFP
March 26, 2023, 8:40 pm
0
8
Southwoods nails Seniors’ Fil golf crown

BERLIN – German Chancellor Olaf Scholz will battle on Sunday to put out the fires threatening his government as the...

Read more

22 leaders sign deal on LatAm food crisis

byAFP
March 26, 2023, 8:30 pm
0
8
Southwoods nails Seniors’ Fil golf crown

SANTO DOMINGO – Twenty-two countries signed a declaration at the Ibero-American Summit in the Dominican Republic on Saturday committing to...

Read more

UN hits Russia, Ukraine forces for POW ‘summary executions’

byAFP
March 25, 2023, 10:00 pm
0
8
Southwoods nails Seniors’ Fil golf crown

KYIV—The United Nations said Friday it was “deeply concerned” by what it said were summary executions of prisoners of war...

Read more

Print Edition

View More

Recent Posts

  • Tornado kills at least 25 in Mississippi
  • Fresh protests in France shift to water dispute
  • Pause Israel reforms, defense minister urges
  • Scholz looks to quell coalition divisions
  • 22 leaders sign deal on LatAm food crisis
  • Bolts level semis series with Tropang Giga
  • Home is where the heart is
  • Hori70n’s debut single tops iTunes PH

Advertisement

Latest News

Bolts level semis series with Tropang Giga

byManila Standard Sports
March 26, 2023, 8:21 pm
0
8
Bolts level semis series with Tropang Giga

By Peter Atencio KJ McDaniel fired a game-high 39 points for the Meralco Bolts, who beat the TNT Tropang Giga...

Read more

Home is where the heart is

byAlwin Ignacio
March 26, 2023, 8:15 pm
0
8
Mel Tiangco, Atom Araullo, GMA online newscast recognized for journalistic excellence   

As diva Diana Ross sings: “When I think of home, I think of a place where there is love overflowing…”...

Read more

Hori70n’s debut single tops iTunes PH

byManila Standard
March 26, 2023, 8:10 pm
0
8
Mel Tiangco, Atom Araullo, GMA online newscast recognized for journalistic excellence   

Pop group Hori7on is starting to make a mark on the global stage as its pre-debut single “Dash” tops iTunes...

Read more

Mel Tiangco, Atom Araullo, GMA online newscast recognized for journalistic excellence   

byManila Standard
March 26, 2023, 8:05 pm
0
8
Mel Tiangco, Atom Araullo, GMA online newscast recognized for journalistic excellence   

Leading broadcast company GMA Network was once again recognized by educational institutions University of the East (UE) Caloocan and De...

Read more

Your little Santorini in Narvacan

byNickie Wang
March 26, 2023, 8:00 pm
0
8
Fili Hotel brings genuine Filipino hospitality to Cebu

Santorini is one of the best places on earth to visit and that’s probably what inspired businessman and former politician...

Read more

Advertisement

ADVERTISEMENT
Facebook Twitter Instagram Youtube

ABOUT US

Manila Standard

Manila Standard website (manilastandard.net), launched in August 2002, extends the newspaper’s reach beyond its traditional readers and makes its brand of Philippine news and opinion available to a much wider and geographically diverse readership here and overseas.

Digital Edition

In tone and content, the online edition mirrors the editorial thrust of the newspaper. While hewing to the traditional precepts of fairness and objectivity, MS believes the news of the day need not be staid, overly long or dry. Stories are succinct, readable and written in a lively style that has become a hallmark of the newspaper.

Download – Today’s Paper

Search

No Result
View All Result

6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines

Trunklines: 832-5554, 832-5556, 832-5558

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Pop.Life
    • Newsmakers
    • Hangouts
    • A-Pop
    • Post Its
    • Performances
    • Malls & Bazaars
    • Hobbies & Collections
  • Technology
    • Gadgets
    • Computers
    • Business
    • Tech Plus
  • MS ON THE ROAD
    • Sedan
    • SUV
    • Truck
    • Bike
    • Accessories
    • Motoring Plus
    • Commuter’s Corner
  • Home & Design
    • Residential
    • Commercial
    • Construction
    • Interior
  • Spotlight
  • Gallery
    • Photos
    • Videos
  • Events
    • Seminars
    • Exhibits
    • Community
  • Biyahero
    • Travel Features
    • Travel Reels
    • Travel Logs
  • Pets
  • Advertise with Us

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Install Manila Standard Web App

Install App